| Year |
Citation |
Score |
| 2020 |
Cho EJ, Devkota AK, Stancu G, Edupunganti R, Debevec G, Giulianotti M, Houghten R, Powis G, Dalby KN. A Robust and Cost-Effective Luminescent-Based High-Throughput Assay for Fructose-1,6-Bisphosphate Aldolase A. Slas Discovery : Advancing Life Sciences R & D. 2472555220926146. PMID 32462959 DOI: 10.1177/2472555220926146 |
0.698 |
|
| 2019 |
Qi R, Walker B, Jing Z, Yu M, Stancu G, Edupuganti R, Dalby KN, Ren P. Computational and Experimental Studies of Inhibitor Design for Aldolase A. The Journal of Physical Chemistry. B. PMID 31268712 DOI: 10.1021/Acs.Jpcb.9B04551 |
0.529 |
|
| 2017 |
Cho EJ, Devkota AK, Stancu G, Edupunganti R, Powis G, Dalby KN. A Fluorescence-Based High-Throughput Assay for the Identification of Anticancer Reagents Targeting Fructose-1,6-Bisphosphate Aldolase. Slas Discovery. 2472555217726325. PMID 28820953 DOI: 10.1177/2472555217726325 |
0.679 |
|
| 2016 |
Tavares CD, Giles DH, Stancu G, Chitjian CA, Ferguson SB, Wellmann RM, Kaoud TS, Ghose R, Dalby KN. Signal Integration at Elongation Factor 2 Kinase; the Roles of Calcium, Calmodulin and Ser-500 Phosphorylation. The Journal of Biological Chemistry. PMID 27956550 DOI: 10.1074/Jbc.M116.753277 |
0.338 |
|
| 2016 |
Grandjean G, De Jong PR, James BP, Koh MY, Lemos R, Kingston J, Aleshin A, Bankston LA, Miller CP, Cho EJ, Edupuganti R, Devkota A, Stancu G, Liddington RC, Dalby KN, et al. Definition of a novel feed-forward mechanism for glycolysis-HIF1α signaling in hypoxic tumors highlights adolase A as a therapeutic target. Cancer Research. PMID 27261507 DOI: 10.1158/0008-5472.Can-16-0401 |
0.706 |
|
| Show low-probability matches. |